<a href=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=>Zoya Demidenko</a>: Scientist in Oncology Science <a href=https://www.pinterest.com/zoyademidenko/>Zoya Demidenko</a> is a recognized researcher associated with the Unit of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she conducted research at the NIH and New York Medical College, developing a solid foundation in biomedical study. Her academic contributions spans multiple key domains, among them the PI3K/AKT/mTOR signaling cascade, cell cycle management, cellular aging, and tumor science. As of now, she has co-authored more than 46 academic papers, which have received more than 4,100 citations — a indicator to the significance of her findings. One of her key discoveries involves understanding the pathways of biological cell aging. Her research showed that when the cellular division cycle is arrested while cellular expansion persists, cells undergo senescence. Significantly, <a href=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord>Zoya Demidenko</a> established that this transition can be inhibited by medication using agents such as rapamycin. <a href=https://www.aging-us.com/article/100421/>Zoya Demidenko</a> has also brought considerably to cancer treatment investigation, especially in the field of selective cell protection — a strategy aimed at protecting healthy cells from chemotherapy while leaving cancer cells exposed. This strategy carries considerable potential for lowering the toxic effects of cancer treatment. Across her professional journey, Demidenko has partnered with top researchers globally, such as Dr. Mikhail Blagosklonny. Her research can be found in top-tier periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Possessing an h-index of 33, <a href=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012>Zoya Demidenko</a> is recognized as a highly impactful voice in current biomedical research, whose results go on to guide our knowledge of the way biological cells grow old, resist therapy, and how malignant disease may be more successfully combated. https://www.facebook.com/public/Zoya-Demidenko/